Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BAY 61-3606

BAY 61-3606 is an orally available, ATP-competitive, reversible and highly selective Syk inhibitor with a Ki of 7.5 nM and an IC50 of 10 nM[1]. BAY 61-3606 reduces ERK1/2 and Akt phosphorylation in neuroblastoma cell[2]. BAY 61-3606 induces a large decrease of Syk phosphorylation in K-rn cell lysates[3]. Bay 61-3606 sensitizes TRAIL-induced apoptosis by downregulating Mcl-1 in breast cancer cells[4].

Product Specifications

CAS Number

[732983-37-8]

UNSPSC

12352005

Hazard Statement

H315-H319-H320

Target

Apoptosis; Syk

Type

Reference compound

Related Pathways

Apoptosis; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bay-61-3606.html

Purity

98.21

Solubility

DMSO : 5 mg/mL (ultrasonic; warming; heat to 80°C)

Smiles

O=C(C1=CC=CN=C1NC2=NC(C3=CC=C(OC)C(OC)=C3)=CC4=NC=CN24)N

Molecular Formula

C20H18N6O3

Molecular Weight

390.40

Precautions

P264-P280-P302+P352-P305+P351+P338-P362

References & Citations

[3]Gioia R, et al. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Blood. 2011 Aug 25;118 (8) :2211-21.|[4]Kim SY, et al. Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells. PLoS One. 2015 Dec 31;10 (12) :e0146073.|[1]Yamamoto N, et al. The orally available spleen tyrosine kinase inhibitor 2-[7- (3,4-dimethoxyphenyl) -imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. J Pharmacol Exp Ther. 2003 Sep;306 (3) :1174-81.|[2]Tümmler C, et al. SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel) . 2019 Feb 10;11 (2) . pii: E202.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-76474/BAY-61-3606-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-76474/BAY-61-3606-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Harvard Medical School LINCS LIBRARY|Hematology. 2025 Dec;30 (1) :2495221.|Int J Mol Sci. 2021 Mar 24;22 (7) :3323.|Research Square Preprint. 2024 Apr 19.|Front Immunol. 2018 Feb 15:9:249.|JCI Insight. 2024 Jun 13:e174746.|Mol Cancer Ther. 2024 Oct 1;23 (10) :1404-1417.|Neuro Oncol. 2018 Apr 9;20 (5) :621-631.|Proc Natl Acad Sci U S A. 2022 Oct 25;119 (43) :e2207280119.
Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

ARID5A Peptide - N-terminal region
MBS3235309-01 0.1 mg

ARID5A Peptide - N-terminal region

Ask
View Details
ARID5A Peptide - N-terminal region
MBS3235309-02 5x 0.1 mg

ARID5A Peptide - N-terminal region

Ask
View Details
Ssh2 Mouse shRNA Plasmid (Locus ID 237860)
TL513552 1 Kit

Ssh2 Mouse shRNA Plasmid (Locus ID 237860)

Ask
View Details
ENSMUSG00000074243 shRNA Plasmid (m)
sc-144868-SH 20 µg

ENSMUSG00000074243 shRNA Plasmid (m)

Ask
View Details
Angpt2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
11895114 3 x 1.0 µg

Angpt2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

Ask
View Details
GPC5 CRISPRa sgRNA lentivector (set of three targets)(Human)
22450121 3 x 1.0μg DNA

GPC5 CRISPRa sgRNA lentivector (set of three targets)(Human)

Ask
View Details